Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

558.87
+13.412.46%
Post-market: 562.994.12+0.74%19:55 EDT
Volume:1.66M
Turnover:920.76M
Market Cap:60.34B
PE:14.17
High:583.28
Open:583.01
Low:542.89
Close:545.46
Loading ...

Regeneron (REGN) Q2 EPS Jumps 53%

Motley Fool
·
Yesterday

Oppenheimer Adjusts Regeneron Pharmaceuticals PT to $800 From $900, Keeps Outperform Rating

MT Newswires Live
·
Yesterday

US FDA declines to approve Regeneron's blood cancer therapy for second time

Reuters
·
01 Aug

Regeneron Pharmaceuticals Shares up 3.6% After Q2 Revenue, Profit Beat

THOMSON REUTERS
·
01 Aug

Stock Track | Regeneron Stock Soars 6.88% as Q2 Earnings Crush Estimates, Dupixent Sales Surge

Stock Track
·
01 Aug

Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines

Benzinga
·
01 Aug

Sector Update: Health Care Stocks Mixed Premarket Friday

MT Newswires Live
·
01 Aug

Regeneron Exec Says Co Currently Do Not Expect a 15% Tariff on Non-Generic Pharmaceutical Products to Have Material Impact on 2025 Results - Conf Call

THOMSON REUTERS
·
01 Aug

Regeneron Pharmaceuticals Unveils Corporate Presentation Highlighting Innovative Pipeline and Genetic Research Breakthroughs

Reuters
·
01 Aug

Regeneron beats second-quarter results estimates on Dupixent sales boost

Reuters
·
01 Aug

Regeneron 2Q Revenue, Adjusted EPS Top Estimates

Dow Jones
·
01 Aug

BRIEF-Regeneron Reports Q2 2025 Financial And Operating Results

Reuters
·
01 Aug

Stock Track | Regeneron Pharmaceuticals Soars 5.06% Pre-market on Strong Q2 2025 Earnings Beat

Stock Track
·
01 Aug

Regeneron reports Q2 non-GAAP EPS $12.89, consensus $8.43

TIPRANKS
·
01 Aug

MORNING BID AMERICAS-Tariff day hits as Amazon stumbles

Reuters
·
01 Aug

Regeneron Shares up 5% Premarket After Q2 Revenue, Profit Beat

THOMSON REUTERS
·
01 Aug

Regeneron Pharmaceuticals Q2 2025 Adj. EPS $12.89 Beats $8.57 Estimate, Sales $3.680B Beat $3.294B Estimate

Benzinga
·
01 Aug

BRIEF-Regeneron Q2 Adjusted EPS USD 12.89 Vs. IBES Estimate USD 8.44

Reuters
·
01 Aug

Regeneron Reports 4% Revenue Growth, 3% GAAP EPS Increase, and 12% Non-GAAP EPS Rise in Q2 2025

Reuters
·
01 Aug

Regeneron Outlook FY Capex USD 880-950 Million

THOMSON REUTERS
·
01 Aug